Potential humoral mediators of remote ischemic preconditioning in patients undergoing surgical coronary revascularization

[1]  Z. Giricz,et al.  Effect of hypercholesterolaemia on myocardial function, ischaemia–reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning , 2017, British journal of pharmacology.

[2]  A. Abbate,et al.  Reduction of Myocardial Ischemia–Reperfusion Injury by Inhibiting Interleukin-1 Alpha , 2017, Journal of cardiovascular pharmacology.

[3]  R. Bonadonna,et al.  Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes , 2017, Cardiovascular Diabetology.

[4]  D. Bonneau,et al.  A Nontargeted UHPLC-HRMS Metabolomics Pipeline for Metabolite Identification: Application to Cardiac Remote Ischemic Preconditioning. , 2017, Analytical chemistry.

[5]  G. Heusch,et al.  Cardiomyocyte mitochondria as targets of humoral factors released by remote ischemic preconditioning , 2016, Archives of medical science : AMS.

[6]  A. Rodríguez-Sinovas,et al.  Remote ischemic conditioning provides humoural cross-species cardioprotection through glycine receptor activation , 2017, Cardiovascular research.

[7]  G. Heusch.  Remote ischemic conditioning: the enigmatic transfer of protection. , 2017, Cardiovascular research.

[8]  M. Bonab.  randomised trial , 2022 .

[9]  G. Heusch,et al.  Cardioprotection by remote ischemic conditioning and its signal transduction , 2016, Pflügers Archiv - European Journal of Physiology.

[10]  Meixiang Xiang,et al.  Interleukin-17A mediates cardiomyocyte apoptosis through Stat3-iNOS pathway. , 2016, Biochimica et biophysica acta.

[11]  A. Gourine,et al.  Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning , 2016, Cardiovascular research.

[12]  S. M. Nouraei,et al.  Does Remote Ischaemic Preconditioning Protect Kidney and Cardiomyocytes After Coronary Revascularization? A Double Blind Controlled Clinical Trial , 2016, Medical archives.

[13]  P. Reynier,et al.  Metabolic Signature of Remote Ischemic Preconditioning Involving a Cocktail of Amino Acids and Biogenic Amines , 2016, Journal of the American Heart Association.

[14]  Cheuk-Man Yu,et al.  Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2 , 2016, Scientific Reports.

[15]  G. Heusch,et al.  Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning. , 2016, Circulation research.

[16]  L. Borthwick.  The IL-1 cytokine family and its role in inflammation and fibrosis in the lung , 2016, Seminars in Immunopathology.

[17]  G. Marx,et al.  The Human Host Defense Ribonucleases 1, 3 and 7 Are Elevated in Patients with Sepsis after Major Surgery—A Pilot Study , 2016, International journal of molecular sciences.

[18]  Ameeta Kelekar,et al.  EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection , 2016, Cell.

[19]  G. Heusch,et al.  Kinetics and Signal Activation Properties of Circulating Factor(s) From Healthy Volunteers Undergoing Remote Ischemic Pre-Conditioning , 2016, JACC. Basic to translational science.

[20]  Christine M. Miller,et al.  EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection , 2016, Cell.

[21]  B. Gersh,et al.  ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not! , 2016, European heart journal.

[22]  J. Nofer,et al.  Establishing Reference Intervals for Sex Hormones on the Analytical Platforms Advia Centaur and Immulite 2000XP , 2015, Annals of laboratory medicine.

[23]  J. Gao,et al.  Remote ischaemic preconditioning reduces myocardial ischaemic reperfusion injury in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2016, Acta cardiologica.

[24]  Z. Shao,et al.  GDF11 Increased in Patients with Myelodysplastic Syndrome , 2015 .

[25]  G. Schuler,et al.  Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial. , 2015, European heart journal.

[26]  Zhang Changjiang,et al.  The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling Pathway , 2015, PloS one.

[27]  K. Preissner,et al.  RNase1 as a potential mediator of remote ischaemic preconditioning for cardioprotection†. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  S. Pizzamiglio,et al.  Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone , 2015, Expert review of proteomics.

[29]  D. Hasenclever,et al.  A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery. , 2015, The New England journal of medicine.

[30]  J. Pepper,et al.  Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. , 2015, The New England journal of medicine.

[31]  K. Clément,et al.  A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial , 2015, PloS one.

[32]  Jun-xian Song,et al.  TRPV1 activation is involved in the cardioprotection of remote limb ischemic postconditioning in ischemia-reperfusion injury rats. , 2015, Biochemical and biophysical research communications.

[33]  D. Yellon,et al.  Remote Ischemic Conditioning Reduces Myocardial Infarct Size in STEMI Patients Treated by Thrombolysis. , 2015, Journal of the American College of Cardiology.

[34]  M. Mayr,et al.  Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification. , 2015, Current drug targets.

[35]  Y. Iwamoto,et al.  Renal Nerve-Mediated Erythropoietin Release Confers Cardioprotection During Remote Ischemic Preconditioning. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[36]  G. Heusch,et al.  Across-Species Transfer of Protection by Remote Ischemic Preconditioning With Species-Specific Myocardial Signal Transduction by Reperfusion Injury Salvage Kinase and Survival Activating Factor Enhancement Pathways. , 2015, Circulation research.

[37]  J. Kellum,et al.  Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. , 2015, JAMA.

[38]  G. Heusch,et al.  Extracellular signalling molecules in the ischaemic/reperfused heart – druggable and translatable for cardioprotection? , 2015, British journal of pharmacology.

[39]  W. Kuo,et al.  Prolactin protects cardiomyocytes against intermittent hypoxia-induced cell damage by the modulation of signaling pathways related to cardiac hypertrophy and proliferation. , 2015, International journal of cardiology.

[40]  G. Heusch.  Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. , 2015, Circulation research.

[41]  M. Waters,et al.  JAK2 activation by growth hormone and other cytokines , 2015, The Biochemical journal.

[42]  P. Schneider,et al.  Cutting Edge: IL-1α Is a Crucial Danger Signal Triggering Acute Myocardial Inflammation during Myocardial Infarction , 2015, The Journal of Immunology.

[43]  S. K. White,et al.  Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. , 2015, JACC. Cardiovascular interventions.

[44]  P. Ferdinandy,et al.  Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning , 2014, Pharmacological Reviews.

[45]  M. Hayward,et al.  Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial , 2014, Heart.

[46]  M. Lesser,et al.  Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease. , 2014, The Journal of clinical investigation.

[47]  R. Gladstone,et al.  MicroRNA-144 is a circulating effector of remote ischemic preconditioning , 2014, Basic Research in Cardiology.

[48]  M. Totzeck,et al.  Circulating Nitrite Contributes to Cardioprotection by Remote Ischemic Preconditioning , 2014, Circulation research.

[49]  G. Heusch,et al.  No Evidence for Activated Autophagy in Left Ventricular Myocardium at Early Reperfusion with Protection by Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting , 2014, PloS one.

[50]  Julian A. Smith,et al.  Understanding noncardiac complications following coronary artery bypass graft surgery , 2014 .

[51]  Zhong-zhi Tang,et al.  O R I G I N a L I N V E S T I G a T I O N Open Access , 2022 .

[52]  H. Bøtker,et al.  Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. , 2014, European heart journal.

[53]  A. Redington,et al.  Remote Cardioprotection by Transfer of Coronary Effluent from Ischemic Preconditioned Rabbit Heart Preserves Mitochondrial Integrity and Function via Adenosine Receptor Activation , 2014, Cardiovascular Drugs and Therapy.

[54]  W. Bao,et al.  Cardioprotection by systemic dosing of thymosin beta four following ischemic myocardial injury , 2013, Front. Pharmacol..

[55]  G. Semenza,et al.  Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart , 2013, Proceedings of the National Academy of Sciences.

[56]  M. Neuhäuser,et al.  Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial , 2013, The Lancet.

[57]  J. Vicencio,et al.  Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis , 2013, Basic Research in Cardiology.

[58]  M. Chwastyniak,et al.  Apolipoprotein A-I Is a Potential Mediator of Remote Ischemic Preconditioning , 2013, PloS one.

[59]  Yumi Kim,et al.  Multiple signaling pathways mediate ghrelin-induced proliferation of hippocampal neural stem cells. , 2013, The Journal of endocrinology.

[60]  Adam J. Brown,et al.  Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective Percutaneous Coronary Intervention: The CRISP Stent Trial Long-term Follow-up , 2013, Circulation. Cardiovascular interventions.

[61]  Richard T. Lee,et al.  Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy , 2013, Cell.

[62]  Kyle D. Bemis,et al.  The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma , 2013, PloS one.

[63]  M. Roden,et al.  Association between Traffic-Related Air Pollution, Subclinical Inflammation and Impaired Glucose Metabolism: Results from the SALIA Study , 2013, PloS one.

[64]  D. Hausenloy,et al.  Protection of organs other than the heart by remote ischemic conditioning , 2013, Journal of cardiovascular medicine.

[65]  E. Ghigo,et al.  GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways. , 2013, Endocrinology.

[66]  I. Konstantinov,et al.  Remote Ischemic Preconditioning (RIPC) Modifies Plasma Proteome in Humans , 2012, PloS one.

[67]  G. Heusch.  HIF-1α and paradoxical phenomena in cardioprotection. , 2012, Cardiovascular research.

[68]  Dan Mercola,et al.  Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer , 2012, PloS one.

[69]  H. Bøtker,et al.  Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients , 2012, Basic Research in Cardiology.

[70]  F. Zhao,et al.  The association of a distinct plasma proteomic profile with the cervical high-grade squamous intraepithelial lesion of Uyghur women: a 2D liquid-phase chromatography/mass spectrometry study , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[71]  K. Ahn,et al.  Chemerin and Adiponectin Contribute Reciprocally to Metabolic Syndrome , 2012, PloS one.

[72]  G. Heusch,et al.  STAT5 Activation and Cardioprotection by Remote Ischemic Preconditioning in Humans , 2012, Circulation research.

[73]  G. Heusch,et al.  Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol – a clinical trial , 2012, Acta anaesthesiologica Scandinavica.

[74]  K. Zen,et al.  Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion. , 2012, Journal of molecular endocrinology.

[75]  B. Bein,et al.  Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study , 2012, Basic Research in Cardiology.

[76]  J. Betts,et al.  Endocrine responses during overnight recovery from exercise: impact of nutrition and relationships with muscle protein synthesis. , 2011, International journal of sport nutrition and exercise metabolism.

[77]  Hongmei Gu,et al.  SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. , 2011, American journal of physiology. Heart and circulatory physiology.

[78]  D. Meldrum,et al.  Interleukin-10 protects the ischemic heart from reperfusion injury via the STAT3 pathway. , 2011, Surgery.

[79]  Li-Ling Wu,et al.  Expression of ghrelin in human salivary glands and its levels in saliva and serum in Chinese obese children and adolescents. , 2011, Archives of oral biology.

[80]  Y. Segev,et al.  Role of growth hormone-releasing hormone in sleep and growth impairments induced by upper airway obstruction in rats , 2011, European Respiratory Journal.

[81]  F. Gao,et al.  Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury. , 2011, Journal of molecular and cellular cardiology.

[82]  P. Riley,et al.  Identification of Thymosin β4 as an effector of Hand1-mediated vascular development , 2010, Nature communications.

[83]  R. Dixon,et al.  Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. , 2010, American journal of physiology. Heart and circulatory physiology.

[84]  C. Terkelsen,et al.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.

[85]  D. Hilfiker-Kleiner,et al.  STAT3 and cardiac remodeling , 2010, Heart Failure Reviews.

[86]  L. Opie,et al.  Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. , 2009, Cardiovascular research.

[87]  Elena Kuzmin,et al.  Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. , 2009, Clinical science.

[88]  S. Lecour.  Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? , 2009, Journal of molecular and cellular cardiology.

[89]  Zhou Xinmin,et al.  Limb Ischemic Preconditioning Reduces Heart and Lung Injury After an Open Heart Operation in Infants , 2009, Pediatric Cardiology.

[90]  G. Heusch,et al.  Cardioprotection: nitric oxide, protein kinases, and mitochondria. , 2008, Circulation.

[91]  H. Drexler,et al.  The myocardial JAK/STAT pathway: from protection to failure. , 2008, Pharmacology & therapeutics.

[92]  P. Boekstegers,et al.  Thymosin β4 Is an Essential Paracrine Factor of Embryonic Endothelial Progenitor Cell–Mediated Cardioprotection , 2008, Circulation.

[93]  Lars Stegger,et al.  Survivin Determines Cardiac Function by Controlling Total Cardiomyocyte Number , 2008, Circulation.

[94]  J. Downey,et al.  Mapping Preconditioning's Signaling Pathways , 2008, Annals of the New York Academy of Sciences.

[95]  C. Garlanda,et al.  Cardioprotective Function of the Long Pentraxin PTX3 in Acute Myocardial Infarction , 2008, Circulation.

[96]  J. Keenan,et al.  Direct cardiac actions of erythropoietin (EPO): effects on cardiac contractility, BNP secretion and ischaemia/reperfusion injury. , 2008, Clinical science.

[97]  G. Heusch.  Nitric Oxide, Protein Kinases, and Mitochondria , 2008 .

[98]  B. Gersh.  Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial , 2008 .

[99]  M. Fishbein,et al.  Role of the JAK/STAT Pathway in the Regulation of Interleukin-8 Transcription by Oxidized Phospholipids in Vitro and in Atherosclerosis in Vivo* , 2007, Journal of Biological Chemistry.

[100]  M. Hayward,et al.  Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial , 2007, The Lancet.

[101]  G. Opelz,et al.  Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy. , 2007, AIDS research and human retroviruses.

[102]  G. Heusch.  Obesity – a risk factor or a RISK factor for myocardial infarction? , 2006, British journal of pharmacology.

[103]  Q. Xia,et al.  &kgr;-Opioid Receptors Mediate Cardioprotection by Remote Preconditioning , 2006, Anesthesiology.

[104]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[105]  R. Bolli,et al.  IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. , 2004, Cardiovascular research.

[106]  Abdulmajeed Al Abdukareem.  Randomized, placebo-controlled trial , 2004, Annals of Saudi medicine.

[107]  D. Liem,et al.  Sites of action of adenosine in interorgan preconditioning of the heart. , 2002, American journal of physiology. Heart and circulatory physiology.

[108]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[109]  E. Dickson,et al.  Rabbit heart can be "preconditioned" via transfer of coronary effluent. , 1999, American journal of physiology. Heart and circulatory physiology.

[110]  V. Emilsson,et al.  Interleukin-1beta activates a short STAT-3 isoform in clonal insulin-secreting cells. , 1999, FEBS letters.

[111]  V. Emilsson,et al.  Interleukin‐1β activates a short STAT‐3 isoform in clonal insulin‐secreting cells , 1999 .

[112]  D. Waxman,et al.  Growth Hormone Activation of Stat 1, Stat 3, and Stat 5 in Rat Liver , 1996, The Journal of Biological Chemistry.

[113]  Keiichiro Suzuki,et al.  Interleukin 1α-induced expression of manganous superoxide dismutase reduces myocardial reperfusion injury in the rat , 1995 .

[114]  W. Leonard,et al.  The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. , 1995, Immunity.

[115]  S. Takahashi,et al.  Interleukin 1 alpha-induced expression of manganous superoxide dismutase reduces myocardial reperfusion injury in the rat. , 1995, Journal of molecular and cellular cardiology.

[116]  N. Maulik,et al.  Interleukin‐1a Preconditioning Reduces Myocardial Ischemia Reperfusion Injury , 1993 .

[117]  N. Maulik,et al.  Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. , 1993, Circulation.

[118]  當代醫學編輯部.  Interleukin-1 alpha與細胞生長 , 1991 .

[119]  P. D. Hart.  Randomised controlled clinical trials. , 1991, BMJ.

[120]  C. Libert,et al.  Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice , 1990, European journal of immunology.

[121]  W. N. Parker,et al.  The Engineering Approach , 1972 .

[122]  E. Glaser.  The randomized clinical trial. , 1972, The New England journal of medicine.